Abstract
Alport syndrome (ATS) is a hereditary nephropathy often associated with sensorineural hypoacusis and ocular abnormalities. Mutations in the COL4A5 gene cause X-linked ATS. Mutations in COL4A4 and COL4A3 genes have been reported in both autosomal recessive and autosomal dominant ATS. The conventional mutation screening, performed by DHPLC and/or Sanger sequencing, is time-consuming and has relatively high costs because of the absence of hot spots and to the high number of exons per gene: 51 (COL4A5), 48 (COL4A4) and 52 (COL4A3). Several months are usually necessary to complete the diagnosis, especially in cases with less informative pedigrees. To overcome these limitations, we designed a next-generation sequencing (NGS) protocol enabling simultaneous detection of all possible variants in the three genes. We used a method coupling selective amplification to the 454 Roche DNA sequencing platform (Genome Sequencer junior). The application of this technology allowed us to identify the second mutation in two ATS patients (p.Ser1147Phe in COL4A3 and p.Arg1682Trp in COL4A4) and to reconsider the diagnosis of ATS in a third patient. This study, therefore, illustrates the successful application of NGS to mutation screening of Mendelian disorders with locus heterogeneity.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG : Alport’s syndrome, Goodpasture’s syndrome, and type IV collagen. N Engl J Med 2003; 348: 2543–2556.
Alport AC : Hereditary familial congenital hemorragic nephritis. Brit Med J 1927; 1: 504–506.
Flinter F : Alport’s syndrome. J Med Genet 1997; 34: 326–330.
Kashtan CE, Michael AF : Alport syndrome. Kidney Int 1996; 50: 1445–1463.
Wing A, Brunner F : Twenty-three years of dialysis and transplantation in Europe: experiences of the EDTA Registry. Am J Kidney Dis 1989; 14: 341–346.
Jais JP, Knebelmann B, Giatras I et al: X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol 2000; 11: 649–657.
Pirson Y : Making the diagnosis of Alport’s syndrome. Kidney Int 1999; 56: 760–775.
Myers JC, Jones TA, Pohjolainen ER et al: Molecular cloning of a5(IV) collagen and assignment of the gene to the region of the X chromosome containing the Alport syndrome locus. Am J Hum Genet 1990; 46: 1024.
Flinter FA, Cameron JS, Chantler C, Houston I, Bobrow M : Genetics of classic Alport’s syndrome. Lancet 1988; ii: 1005–1007.
Kashtan CE : Alport syndrome and the X chromosome: implications of a diagnosis of Alport syndrome in females. Nephrol Dial Transplant 2007; 22: 1499–1505.
Jais JP, Knebelmann B, Giatras I et al: X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a ‘European Community Alport Syndrome Concerted Action’ Study. J Am Soc Nephrol 2003; 14: 2603–2610.
Longo I, Porcedda P, Mari F et al: COL4A3/A4 mutation: from benign familial hematuria to autosomal dominant or recessive Alport syndrome. Kidney Int 2002; 61: 1947–1956.
Marcocci E, Uliana V, Bruttini M et al: Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome. Nephrol Dial Transplant 2009; 24: 1464–1471.
Smeets HJ, Lemmik HH, Van Den Heuvel LP : Molecular and immunological studies in X-linked and autosomal recessive in Alport syndrome. Am J Hum Genet 1993; 53: 1230.
Mochizuki T, Lemmink HH, Maryiama M et al: Identification of mutations in the a3(IV) and a4(IV) collagen genes in autosomal recessive Alport syndrome. Nat Genet 1994; 8: 77–82.
Knebelmann B, Benessy F, Buemi M, Grunfeld JP, Gubler MC, Antignac C : Autosomal recessive (AR) inheritance in Alport syndrome (AS). J Am Soc Nephrol 1993; 4: 263.
Jefferson JA, Lemmink HH, Hughes AE et al: Autosomal dominant Alport Syndrome linked to the type IV collagen a3 and a4 genes (COL4A3 and COL4A4). Nephrol Dial Transplant 1997; 12: 1595–1599.
van der Loop FT, Heidet L, Timmer ED et al: Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney Int 2000; 58: 1870–1875.
Ciccarese M, Casu D, Ki Wong F et al: Identification of a new mutation in the alpha4(IV) collagen gene in a family with autosomal dominant Alport syndrome and hypercholesterolaemia. Nephrol Dial Transplant 2001; 16: 2008–2012.
Pescucci C, Mari F, Longo I et al: Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene. Kidney Int 2004; 65: 1598–1603.
Nyren P, Pettersson B, Uhlen M : Solid phase DNA minisequencing by an enzymatic luminometric inorganic pyrophosphate detection assay. Anal Biochem 1993; 208: 171–175.
Ronaghi M, Karamohamed S, Pettersson B, Uhlen M, Nyren P : Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem 1996; 242: 84–89.
Ronaghi M, Uhlen M, Nyren P : A sequencing method based on real-time pyrophosphate. Science 1998; 281: 363, 365.
Barker DF, Denison JC, Atkin CL, Gregory MC : Efficient detection of Alport syndrome COL4A5 mutations with multiplex genomic PCR-SSCP. Am J Med Genet 2001; 98: 148–160.
Tazon Vega B, Badenas C, Ars E et al: Autosomal recessive Alport’s syndrome and benign familial hematuria are collagen type IV diseases. Am J Kidney Dis 2003; 42: 952–959.
Badenas C, Praga M, Tazon B et al: Mutations in theCOL4A4 and COL4A3 genes cause familial benign hematuria. J Am Soc Nephrol 2002; 13: 1248–1254.
Boye E, Mollet G, Forestier L et al: Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport Syndrome. Am J Hum Genet 1998; 63: 1329–1340.
Lemmink HH, Mochizuki T, van der Heuvel LP et al: Mutations in the type IV collagen a3(COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet 1994; 3: 1269–1273.
Heidet L, Arrondel C, Forestier L et al: Structure of the human type IV collagen gene COL4A3 and mutations in autosomal Alport Syndrome. J Am Soc Nephrol 2001; 12: 97–106.
Voelkerding KV, Dames S, Durtschi JD : Next generation sequencing for clinical diagnostics-principles and application to targeted resequencing for hypertrophic cardiomyopathy: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn 2010; 12: 539–551.
Ansorge WJ : Next-generation DNA sequencing techniques. N Biotechnol 2009; 25: 195–203.
Nagel M, Nagorka S, Gross O : Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. Hum Mutat 2005; 26: 60.
Longo I, Scala E, Mari F et al: Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families. Nephrol Dial Transplant 2006; 21: 665–671.
Hou P, Chen Y, Ding J, Li G, Zhang H : A novel mutation of COL4A3 presents a different contribution to Alport syndrome and thin basement membrane nephropathy. Am J Nephrol 2007; 27: 538–544.
Tan R, Colville D, Wang YY, Rigby L, Savige J : Alport retinopathy results from ‘Severe’ COL4A5 mutations and predicts early renal failure. Clin J Am Soc Nephrol 2010; 5: 34–38.
Raca G, Jackson C, Warman B, Bair T, Schimmenti LA : Next generation sequencing in research and diagnostics of ocular birth defects. Mol Genet Metab 2010; 100: 184–192.
Smith DR, Quinlan AR, Peckham HE et al: Rapid whole-genome mutational profiling using next-generation sequencing technologies. Genome Res 2008; 18: 1638–1642.
Chou LS, Liu CS, Boese B, Zhang X, Mao R : DNA sequence capture and enrichment by microarray followed by next-generation sequencing for targeted resequencing: neurofibromatosis type 1 gene as a model. Clin Chem 2010; 56: 62–72.
Acknowledgements
We first thank ATS patients and their families. We also thank Dr Michele Iacono for his technical support. This work was supported by Regione Toscana project (Progetto Regionale malattie rare) to AR and by a donation to AR ideally dedicated to ‘Graziano and Marco Laurini’.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on European Journal of Human Genetics website
Rights and permissions
About this article
Cite this article
Artuso, R., Fallerini, C., Dosa, L. et al. Advances in Alport syndrome diagnosis using next-generation sequencing. Eur J Hum Genet 20, 50–57 (2012). https://doi.org/10.1038/ejhg.2011.164
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2011.164
Keywords
This article is cited by
-
Variants in genes coding for collagen type IV α-chains are frequent causes of persistent, isolated hematuria during childhood
Pediatric Nephrology (2023)
-
New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells
European Journal of Human Genetics (2020)
-
Expert consensus guidelines for the genetic diagnosis of Alport syndrome
Pediatric Nephrology (2019)
-
A protocol for the identification and validation of novel genetic causes of kidney disease
BMC Nephrology (2015)
-
Clinical utility gene card for: Alport syndrome – update 2014
European Journal of Human Genetics (2015)